Can Postmenopausal Hormone Replacement Improve Plasma Lipids in Women With Diabetes?

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Diabetes Care

• Publication date

  1996-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diacare.19.5.480PMID 8732713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of estrogens and progestins on high density lipoproteins

  2006cited by this paper
• Counseling Postmenopausal Women About Preventive Hormone Therapy *

  1996cited by this paper
• Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

  1995cited by this paper
• National Cholesterol Education Program, second report of the Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults.

  1995cited by this paper
• Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women.

  1994cited by this paper
• Hypertriglyceridemia: risks and perspectives.

  1992cited by this paper
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

  1992cited by this paper
• Plasma triglyceride and coronary heart disease.

  1991cited by this paper
• Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.

  1991cited by this paper
• A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.

  1991cited by this paper
• Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women.

  1990cited by this paper
• A Prospective One-Year Study of Estrogen and Progestin in Postmenopausal Women: Effects on Clinical Symptoms and Lipoprotein Lipids

  1989cited by this paper
• Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study.

  1988cited by this paper
• Effect of blood collection and processing on radioimmunoassay results for apolipoprotein B in plasma.

  1988cited by this paper
• Effect of blood collection and processing on radioimmunoassay results for apolipoprotein A-I in plasma.

  1988cited by this paper
• Anthropometric reference data and prevalence of overweight, United States, 1976-80.

  1987cited by this paper
• Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

  1987cited by this paper
• Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects.

  1987cited by this paper
• Reagent for the Enzymatic Determination of Serum Total Triglycerides with Improved Lipolytic Efficiency

  1984cited by this paper
• A community study of high density lipoproteins in adult noninsulin-dependent diabetics.

  1983cited by this paper
• Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency.

  1983cited by this paper
• A short questionnaire for the measurement of habitual physical activity in epidemiological studies.

  1982cited by this paper
• Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study.

  1977cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia.

  1972cited by this paper

• Current evidence and research gaps in menopause management in women with type 1 diabetes mellitus: a narrative review

  2025cites this paper
• The effect of tibolone treatment on fasting blood sugar, insulin, insulin resistance and endothelial function in postmenopausal women: A meta-analysis of randomized controlled trials.

  2021cites this paper
• Assessing the Magnitude and Risk Factors Associated With Undiagnosed Hypertension in Rural Rwanda

  2019cites this paper
• The Effect of Hormone Replacement Therapy on Cardiovascular Risk Factors in Type 2 Diabetes

  2017cites this paper
• Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus

  2014cites this paper
• UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO

  2014cites this paper
• Hormone replacement therapy for women with type 1 diabetes mellitus.

  2013cites this paper
• Understanding the effect of the menopause in diabetes

  2013cites this paper
• Women's trust in and use of information sources in the treatment of menopausal symptoms.

  2009cites this paper
• Traitement médicamenteux du diabète de type 2

  2008cites this paper
• Hormone replacement therapy and diabetes

  2008cites this paper
• l Diretriz brasileira sobre prevenção de doenças cardiovasculares em mulheres climatéricas e a influência da terapia de reposição hormonal (TRH) da Sociedade Brasileira de Cardiologia (SBC) e da Associação Brasileira do Climatério (SOBRAC)

  2008cites this paper
• Hormone replacement therapy, cardiovascular risk and diabetes

  2007cites this paper
• Use, intentions, and beliefs about hormone replacement therapy in women with and without diabetes.

  2006cites this paper
• Bibliography. Current world literature.

  2006cites this paper
• Association of Type 2 Diabetes Mellitus and Seroprevalence for Cytomegalovirus

  2005cites this paper
• Terapêutica com tibolona em mulheres diabéticas na pós-menopausa: parâmetros clínicos e laboratoriais de segurança

  2005cites this paper
• [Tibolone treatment of diabetic postmenopausal women: clinical and laboratory safety parameters].

  2005cites this paper
• Role of Estrogens in Vascular Disease in Diabetes

  2005cites this paper
• Cholecystitis, Biliary Tract Surgery, and Pancreatitis

  2004influential citation
• Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes *

  2004cites this paper
• Associations of Postmenopausal Hormone Therapy with Markers of Hemostasis and Inflammation and Lipid Profiles in Diabetic and Nondiabetic American Indian Women: The Strong Heart Study

  2004cites this paper
• Gender, hyperlipidemia, and coronary artery disease

  2003cites this paper
• The Effects of Transdermal Estradiol Alone or with Cyclical Dydrogesterone on Markers of Cardiovascular Disease Risk in Postmenopausal Women with Type 2 Diabetes: A Pilot Study

  2003cites this paper
• Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes.

  2003cites this paper
• The neointimal response to endovascular injury is increased in obese Zucker rats

  2003cites this paper
• INFLAMMATION IN DIABETIC WOMEN WITH CARDIOVASCULAR DISEASE

  2003cites this paper
• An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia.

  2003cites this paper
• Atherogenic Lipid Phenotype and Lipoprotein (a) in Diabetes

  2002cites this paper
• Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus

  2002cites this paper
• Hormone Replacement Therapy in Postmenopausal Women with Diabetes Mellitus

  2002cites this paper
• Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial.

  2002cites this paper
• Molecular mechanisms of diabetic cardiovascular disease.

  2002cites this paper
• Lipids and Diabetes Mellitus: A Review of Therapeutic Options

  2002cites this paper
• [Effect of hormone replacement therapy on blood serum lipids in postmenopausal women with type 2 diabetes].

  2002cites this paper
• The effect of hormone replacement therapy on cardiovascular risk factors in type 2 diabetes: a randomized controlled trial.

  2001cites this paper
• The Use of Hormone Replacement Therapy in Postmenopausal Women with Type 2 Diabetes

  2001cites this paper
• Coronary artery disease in women: different, often undertreated.

  2001cites this paper
• [Hormone replacement therapy at menopause in the diabetic woman].

  2001cites this paper
• Effects of estrogen/medrogestone therapy on the apoprotein B-containing lipoproteins in postmenopausal women with type 2 diabetes mellitus under satisfactory and non-satisfactory glycemic control.

  2001cites this paper
• HRT in women with diabetes--review of the effects on glucose and lipid metabolism.

  2001cites this paper
• Physician Gender and Hormone Replacement Therapy Discussion

  2001cites this paper
• Vascular effects of estrogen in type II diabetic postmenopausal women.

  2001cites this paper
• Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.

  2000cites this paper
• Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes.

  2000cites this paper
• Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial.

  2000cites this paper
• Lipoproteins and low‐dose estradiol replacement therapy in post‐menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate

  2000cites this paper
• The effects of hormone replacement therapy on plasma lipids in type II diabetes.

  2000cites this paper
• Pharmacodynamics of Oestrogens and Progestogens

  2000cites this paper
• Diabetic Dyslipidaemia Current Treatment Recommendations

  2000cites this paper
• Hormone replacement therapy, cardiovascular risk factors and diabetes

  2000cites this paper
• Hormone Replacement Therapy in Postmenopausal Women With Diabetes Mellitus

  2000cites this paper
• Improving the adverse cardiovascular prognosis of type 2 diabetes.

  1999cites this paper
• Screening for cardiovascular disease. Concepts, conflicts, and consensus.

  1999cites this paper
• Effect of 17-beta estradiol on pre-existing atherosclerotic lesions: role of the endothelium.

  1999cites this paper
• Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study.

  1999cites this paper
• [Heparin and insulin in the treatment of acute hypertriglyceridemia-induced pancreatitis].

  1999cites this paper
• Hormonal choices after gestational diabetes. Subsequent pregnancy, contraception, and hormone replacement.

  1998cites this paper
• Estrogen induces glomerulosclerosis in analbuminemic rats.

  1998cites this paper
• Hormone replacement therapy in Type 2 diabetes mellitus: a cardiovascular perspective

  1998cites this paper
• Postmenopausal Estrogens and Risk of Myocardial Infarction in Diabetic Women

  1998cites this paper
• Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.

  1998cites this paper
• [Age related decrease of high density lipoproteins (HDL) in women after menopause. Quantification of HDL with genetically determined HDL arylesterase in women with healthy coronary vessels and in women with angiographically verified coronary heart disease].

  1998cites this paper
• Zur altersabhängigen Verminderung von Lipoproteinen hoher Dichte (HDL) bei Frauen nach der Menopause

  1998cites this paper
• Metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes mellitus.

  1998cites this paper
• Lipid and Lipoprotein Responses to Oral Combined Hormone Replacement Therapy in Normolipemic Obese Women with Controlled Type 2 Diabetes Mellitus

  1998cites this paper
• Menopause in normal and uncomplicated NIDDM women: physical and emotional symptoms and hormone profile.

  1997cites this paper
• [Hormonal replacement therapy in women with metabolic disorders].

  1997cites this paper
• Hormone Replacement Preparations and Hypertriglyceridemia in Women With NIDDM

  1997cites this paper
• Evaluation and management of the hormone replacement therapy (HRT) candidate.

  1997cites this paper
• Response to Sattar and Jaap

  1997cites this paper
• Estradiol concentrations in premenopausal women with coronary heart disease

  1997cites this paper
• The clinical decision regarding hormone replacement therapy.

  1997cites this paper
• Hormone replacement therapy, diabetes and pancreatitis secondary to hypertriglyceridaemia.

  1997cites this paper
• Women and Diabetes

  1996cites this paper